Medical devices, healthcare technology and the business of care
510(k) clearance · K260044

Ventricular Catheters, Thomale Catheter

AESCULAP, INC. · Decision date Oct 2, 2026

MEDTECHLEDGER EXPLANATIONK260044

What did the FDA decide?

FDA recorded a substantially equivalent (SESE) decision on 02 October 2026 for K260044, a traditional 510(k) from Aesculap, Inc. of Center Valley, Pennsylvania, covering Ventricular Catheters, Thomale Catheter. The device falls under regulation 882.5550, classification name Shunt, Central Nervous System And Components, with primary product code JXG and subsequent product code HCA; the regulation medical specialty and review panel are both Neurology. The application was received 01 January 2026 and was not reviewed by a third party.

SESE means the submission was cleared as substantially equivalent to a predicate; it is not a PMA approval. The record lists no combination product and no authorized predetermined change control plan, and the source provides no summary statement, so the specific predicate device, the components or modifications assessed, and any performance data remain unknown. The same FDA final-decisions listing dated 02 October 2026 also records K261741 and K260064, which are separate applications unrelated to this one.

Regulatory pathway
510(k) premarket notification
Clinical specialty
Neurology
Decision date
Oct 2, 2026

FDA source record · MedtechLedger’s explanation describes the recorded change.

Regulatory record facts

Identifier
K260044
Regulatory pathway
510(k) premarket notification
Product code
JXG
Decision code
SESE
Decision date
Oct 2, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Shunt, Central Nervous System And Components.

Product code
JXG
FDA device class
2

FDA decision timeline

  1. K260044 received

    Application receipt date recorded by FDA.

  2. K260044 · FDA decision

    SESE

Related devices and submissions

Explore the linked device profile

No additional submissions with a verified PMA or product-code relationship are linked here.

Regulatory context

A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

AESCULAP, INC.

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
Center Valley, PA

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records